Hypoxic-ischemic encephalopathy (HIE) represents one of the most devastating clinical challenges in neonatal medicine, arising when the neonatal brain suffers from oxygen deprivation combined with restricted blood flow. This injury leads to both acute mortality and chronic neurological impairments, including cerebral palsy, cognitive disabilities, and epilepsy. Therapeutic hypothermia—lowering the infant’s body temperature to approximately 33–34°C—remains the only evidence-based treatment that can reduce mortality and improve neurological outcomes. However, the limitations and accessibility issues associated with cooling therapy underscore the need for innovative and complementary treatments.

The concept behind using breast milk as a neuroprotective agent stems from its rich composition of biologically active components, including stem cells, cytokines, growth factors, and neurotrophic substances. These elements have shown potential to support neurogenesis, reduce inflammation, and promote repair in damaged neural tissues. Unlike oral administration, the intranasal route capitalizes on the unique anatomical connection between the nasal mucosa and the central nervous system, allowing breast milk constituents to bypass the blood-brain barrier and directly access the brain through the olfactory and trigeminal nerve pathways.

In the clinical protocol established at Semmelweis University, the treatment commenced within 48 hours after birth, coinciding with the critical therapeutic window for optimal neuroprotection in HIE. Fresh breast milk was meticulously collected from each infant’s mother and carefully administered into the nostrils under rigorous clinical supervision. The meticulous monitoring ensured the detection of any potential adverse respiratory or neurological reactions. Following the initial clinical phase, the therapy was transitioned to a home-based setting, wherein trained parents continued the intranasal administration for 28 consecutive days, supported by ongoing remote monitoring.

Remarkably, the study found no respiratory, circulatory, or neurological adverse events attributable to the intranasal breast milk treatment. This finding establishes a critical foundation for the safety profile of the procedure, affirming that breast milk, when delivered through the nasal passages, does not compromise neonatal physiological stability. This safety confirmation is a vital step before any large-scale efficacy trials can be pursued, providing reassurance to clinicians and families considering this innovative modality.

One of the notable obstacles encountered during the study was logistical rather than medical. The procurement and transport of breast milk from mothers residing in remote locations posed significant challenges. Dr. Ünőke Méder described instances where she personally traveled to distant, rural farms to collect milk, navigating difficult terrain where access was frequently impeded. These logistical complexities underscored not only the infrastructural demands of conducting such novel clinical research but also the psychosocial stress borne by families coping with traumatic early life events.

Supporting lactation among mothers who had undergone the emotional strain of a seriously ill newborn was another critical component of the study’s success. Initiating and maintaining breast milk expression under intense psychological pressure required specialized counseling and clinical support. This aspect highlighted the holistic nature of neonatal care, where maternal well-being and infant treatment strategies are deeply interconnected and must be addressed simultaneously to optimize outcomes.

From the parental perspective, engagement was more positive than initially anticipated. As Dr. Eszter Tarjányi noted, many parents found empowerment and solace in contributing directly to their infant’s care during a period fraught with uncertainty. Learning the precise technique for intranasal administration proved straightforward once the parents understood that the process was painless and safe for their child. This unexpected ease of parental involvement could play a crucial role in the future scalability and acceptability of the therapy.

The current research focuses exclusively on establishing the safety of intranasal breast milk administration in clinically and home-monitored environments. While the biological rationale and preclinical animal models are compelling, the effectiveness and long-term neurological benefits of this therapy remain to be rigorously evaluated in larger, controlled clinical trials. Existing studies from Germany and Canada on preterm infants with brain hemorrhages have previously hinted at potential neuroprotective effects of intranasal breast milk, lending preliminary clinical credence to this approach.

Should subsequent investigations confirm efficacy, intranasal breast milk therapy could revolutionize neonatal care, particularly in resource-limited settings where conventional cooling therapy is unavailable or impractical. The simplicity, cost-effectiveness, and biological compatibility of using a mother’s own fresh milk as a therapeutic agent would offer a sustainable, low-risk approach to addressing neonatal brain injury worldwide. Moreover, this method could extend neuroprotective care beyond hospital walls, integrating into home healthcare frameworks.

International interest in this therapeutic concept is already growing, with several countries exploring opportunities to adapt and implement the intranasal breast milk protocol. Such global collaborations would facilitate the collection of broader clinical data, drive standardized training programs for families and healthcare providers, and address cultural and infrastructural barriers. Through these efforts, intranasal breast milk therapy may emerge as a critical component of comprehensive neonatal neuroprotection strategies.

In summary, the research conducted at Semmelweis University pioneers a promising frontier in neonatal therapeutic interventions. By harnessing breast milk’s unique biological potential and combining it with innovative delivery methods, clinicians are charting a path toward safer, more accessible, and efficacious treatments for newborns afflicted by hypoxic-ischemic brain injuries. Establishing safety in real-world settings lays the groundwork for future studies that could ultimately transform global health outcomes for this vulnerable population.

Subject of Research: Neonatal hypoxic-ischemic brain injury and intranasal breast milk therapy
Article Title: Intranasal Breast Milk as a Novel Neuroprotective Treatment for Brain-Injured Newborns: A Safety Study
News Publication Date: Early 2025
Web References:

• Study published in Pediatric Research: https://www.nature.com/articles/s41390-026-04847-2
• DOI: 10.1038/s41390-026-04847-2
  Image Credits: Semmelweis University, Budapest, Hungary
  Keywords: Hypoxic-ischemic encephalopathy, neonatology, intranasal therapy, breast milk, neuroprotection, therapeutic hypothermia, brain injury, neonatal care, stem cells, neurotrophic factors, clinical safety, home-based therapy

Upper extremity rehabilitation in children with hemiparetic CP is notoriously complex due to the diverse neurological impairments that limit precise motor control. Traditional therapies often struggle to induce meaningful, lasting changes in motor function. Acknowledging these limitations, the research team conceptualized a hybrid protocol intertwining nonlinear dynamic principles with modern therapeutic gaming. The cutting-edge mechanical stimulation targets cutaneous mechanoreceptors on the back of the affected hand, provoking neural responses through patterns derived from a chaotic mathematical framework — a strategy inspired by the brain’s inherent nonlinear self-organizing properties.

The chaotic model implemented in this study serves as a sophisticated generator of mechanical stimuli, creating unpredictable yet structured patterns that challenge and engage the somatosensory system. By avoiding monotonous stimulation, which the nervous system quickly habituates to, the chaotic sequences maintain heightened neural responsiveness. This innovative stimulus design aims to capitalize on the brain’s adaptability, encouraging the formation of new neural connections necessary for motor skill recovery. The combination with game-based exercises further enhances this effect by promoting patient motivation and active participation.

To evaluate the effectiveness of the combined intervention, the researchers conducted a pilot study involving four pediatric participants diagnosed with unilateral CP. This pilot design allowed for a detailed exploratory assessment, focusing on both clinical outcomes and neuromuscular dynamics. By integrating clinical motor function tests with advanced electromyography (EMG) analyses, the study uniquely bridges functional improvements with underlying physiological changes, providing a comprehensive understanding of rehabilitation impacts.

Findings from the study revealed encouraging clinical improvements, particularly in wrist flexion and extension motions. These gains, observed following the combined mechanical and game-based training, underscore the potential for meaningful recovery of movement in a population often resistant to conventional therapies. Importantly, these improvements suggest the intervention’s capacity not only to enhance muscle strength but to refine motor control and coordination, critical components of functional hand use.

The exploration of EMG signals offered provocative insights into the neuromuscular adaptations initiated by the protocol. Employing nonlinear signal processing techniques, the research team detected alterations in muscle activation patterns and temporal coordination. Such changes are indicative of the nervous system’s reorganization towards establishing a novel motor program. This phenomenon, reflective of neuroplasticity, is foundational for long-term rehabilitation success, signifying that the brain and muscular system can relearn and adapt through the applied stimulation.

Moreover, the dual modality intervention addresses a pivotal factor in rehabilitation effectiveness: patient engagement. The inclusion of game-based exercises transforms therapy sessions into interactive experiences that sustain attention and motivation. This engagement is crucial in pediatric populations, where motivation heavily influences therapy adherence and outcomes. By aligning mechanical stimulation with enjoyable game mechanics, the protocol simultaneously tackles neurological and psychological facets of recovery.

The theoretical underpinnings of this study draw heavily from nonlinear dynamics and chaos theory, disciplines traditionally applied in physics and mathematics but now finding novel applications in biomedical engineering. The chaotic stimulation paradigm exemplifies how complex systems theory can inspire innovative medical interventions, suggesting that controlled complexity within stimuli may be pivotal in optimizing neural rehabilitation.

Importantly, this research also highlights the methodological synergy between clinical assessment and signal processing. By applying advanced computational analyses to EMG data, the authors transcend traditional clinical observation, unveiling subtleties in muscle function and neural coordination that are otherwise imperceptible. This integrative assessment model may set a precedent for future rehabilitation research, emphasizing the value of interdisciplinary approaches.

Despite the promising outcomes, the study acknowledges its pilot nature and the limited sample size. However, the initial findings pave a fertile path for subsequent research trials involving larger cohorts and longer follow-up periods. Further investigations will be critical in validating the reproducibility of results and refining stimulation protocols to maximize therapeutic gains.

This study’s convergence of chaotic nonlinear stimulation with game-based therapeutic exercise embodies a broader trend in rehabilitation medicine—leveraging complexity and interactivity to harness neuroplastic mechanisms. As neural recovery increasingly comes to the forefront of clinical practice, interdisciplinary innovations like this herald a new era of personalized, effective therapies designed to improve quality of life for children affected by cerebral palsy.

In conclusion, the integration of mathematically modeled mechanical stimulation with interactive gamified exercises opens new horizons in pediatric neurorehabilitation. Through detailed clinical and neuromuscular analyses, the research under review substantiates the feasibility of this approach in fostering significant motor improvements in children living with unilateral spastic CP. The study represents a compelling example of how advanced engineering concepts and human-centered design can synergize to transform therapeutic interventions, potentially reshaping standards of care in the years to come.

Subject of Research: Upper extremity neurorehabilitation in children with unilateral cerebral palsy using nonlinear mechanical stimulation and game-based exercise.

Article Title: Combining nonlinear mechanical stimulation via a chaotic mathematical model and game-based exercise for upper extremity rehabilitation in children with spastic hemiparetic cerebral palsy: a pilot study.

Article References: Hosseini, P., Hashemi, M.E., Fard, Z.Z. et al. Combining nonlinear mechanical stimulation via a chaotic mathematical model and game-based exercise for upper extremity rehabilitation in children with spastic hemiparetic cerebral palsy: a pilot study. BioMed Eng OnLine 24, 116 (2025). https://doi.org/10.1186/s12938-025-01411-7

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12938-025-01411-7